Halbert Hargrove Global Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Halbert Hargrove Global Advisors's NVS Position: Q2 2026 in Review
Halbert Hargrove Global Advisors opened a new position in Novartis (NVS) in Q2 2026: 15 shares worth $2.34K. The stake represents ﹤0.01% of the portfolio and ranks #377 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in NVS as recently as Q3 2025.
Halbert Hargrove Global Advisors first reported a position in NVS in Q1 2025 and has held it in 3 quarters since. The position peaked at $7.6K in Q3 2025. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Halbert Hargrove Global Advisors held 15 shares of Novartis worth $2.34K as of Q2 2026.
- Novartis was a new Halbert Hargrove Global Advisors position in Q2 2026.
- Novartis made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #377 holding.
- Halbert Hargrove Global Advisors first reported a position in Novartis in Q1 2025 and has held it in 3 quarters since.
- Halbert Hargrove Global Advisors's Novartis position peaked at $7.6K in Q3 2025.
- 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.